All HHS-OIG articles
-
News BriefDrug company and CEO pay $47 million over alleged kickbacks and false claims
A pharmaceutical company and its chief executive have agreed to pay $47 million to settle allegations first brought by whistleblowers, that the company paid kickbacks and filed false claims, the Department of Justice said.
-
OpinionTen things I’d like to see happen in 2024
Election years in the United States, United Kingdom, and at European Parliament, along with ongoing geopolitical tensions, make 2024 difficult to predict—aside from the expectation compliance officers will be busy.
-
PremiumThree areas for leveling up continuous compliance review and monitoring
Compliance professionals often do not think broadly enough about what can and should fall under the umbrella of monitoring and review that will positively impact their ethics and compliance programs. Mary Shirley offers suggestions for program elements to review.
-
News BriefHHS publishes updated healthcare compliance guidance
New guidance from the Department of Health and Human Services is designed to apply generally to the healthcare industry, from doctors to pharmaceutical manufacturers, and help all such entities self-monitor their compliance and prevent waste, fraud, and abuse.
-
ArticleRare OIG Special Fraud Alert cautions the use of speaker programs
In a rare move, the U.S. Department of Health and Human Services’ Office of Inspector General issued a Special Fraud Alert warning of inherent fraud and abuse risks associated with speaker programs.
-
ArticleSaber Healthcare Group to pay $10M in False Claims Act case
The Department of Justice fined Saber Healthcare Group and its related entities $10 million for violations of the False Claims Act, alleging the company knowingly increased Medicare billings.